| __timestamp | TG Therapeutics, Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 31354781 | 21263000 |
| Thursday, January 1, 2015 | 43445817 | 18890000 |
| Friday, January 1, 2016 | 66489820 | 15295000 |
| Sunday, January 1, 2017 | 96886134 | 12944000 |
| Monday, January 1, 2018 | 153793000 | 13599000 |
| Tuesday, January 1, 2019 | 148369000 | 30391000 |
| Wednesday, January 1, 2020 | 151934000 | 13020000 |
| Friday, January 1, 2021 | 198532000 | 16287000 |
| Saturday, January 1, 2022 | 112128000 | 19943000 |
| Sunday, January 1, 2023 | 76192000 | 21042000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are pivotal for innovation and growth. Over the past decade, TG Therapeutics, Inc. has consistently outpaced Vericel Corporation in R&D spending. From 2014 to 2023, TG Therapeutics increased its R&D expenses by approximately 143%, peaking in 2021. In contrast, Vericel's R&D investment grew by a modest 1% over the same period, with a notable spike in 2019.
TG Therapeutics' aggressive investment strategy reflects its commitment to pioneering treatments, while Vericel's steady approach suggests a focus on optimizing existing technologies. This divergence highlights the varied strategies within the biotech sector, where innovation and sustainability must be balanced. As we look to the future, these trends offer insights into the potential trajectories of these companies in the competitive biotech arena.
Who Prioritizes Innovation? R&D Spending Compared for Gilead Sciences, Inc. and Vericel Corporation
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
TG Therapeutics, Inc. or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: TG Therapeutics, Inc. vs Ligand Pharmaceuticals Incorporated
Comparing Innovation Spending: Ultragenyx Pharmaceutical Inc. and Vericel Corporation
R&D Spending Showdown: Perrigo Company plc vs Vericel Corporation
Research and Development Investment: Vericel Corporation vs MannKind Corporation
Analyzing R&D Budgets: Vericel Corporation vs Wave Life Sciences Ltd.
R&D Spending Showdown: Vericel Corporation vs Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.